Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

  • Philip Brouwer, Tom Caniels, Karlijn van Straten, Jonne Snitselaar, Yoann Aldon, Sandhya Bangaru, Jonathan Torres, Nisreen Okba, Mathieu Claireaux, Gius Kerster, Arthur Bentlage, Marlies van Haaren, Denise Guerra, Judith Burger, Edith Schermer, Kirsten Verheul, Niels van der Velde, Alex van der Kooi, Jelle van Schooten, Marielle van Breemen, Tom Bijl, Kwinten Sliepen, Aafke Aartse, Ronald Derking, Ilja Bontjer, Neeltje Kootstra, Joost Wiersinga, Gestur Vidarsson, Bart Haagmans, Andrew Ward, Godelieve de Bree, Rogier Sanders, Marit van Gils
  • May 2020, Cold Spring Harbor Laboratory Press
  • DOI: 10.1101/2020.05.12.088716

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1101/2020.05.12.088716

The following have contributed to this page: Dr Bart L. Haagmans